The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs
Abstract
An oil-adjuvanted inactivated encephalomyocarditis (EMC) vaccine was developed to protect a wild population of elephants against a natural outbreak of disease. The experimental vaccine was initially tested for efficacy by challenging mice and pigs. Mice showed protection against challenge and pigs developed high antibody levels. Since both vaccinated and control pigs failed to develop clinical disease, apparently due to the low virulence of the strain in this species, protection in pigs could not be evaluated. Vaccinated elephants developed high antibody titers which protected all vaccinates from a challenge roughly two months post-vaccination, whereas controls developed fatal or sub-clinical myocarditis. This is the first report of an inactivated EMC vaccine inducing high antibody titers in domestic and wild animal species. Due to the potency of this vaccine and the acceptability of the oil adjuvant used, it has potential for use in animals in zoological collections as well as in the pig industry.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
It is likely that zoo animals may be exposed to EMCV more frequently than believed and that infection in elephants may not always result in severe clinical disease.
“it is likely suggestive that zoo animals may be exposed to EMCV more frequently than believed and that infection in elephants may not always result in severe clinical disease, as has been observed previously in some cases [32].”
From Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak (2026) · cites this paper as [32]
Killed autogenous vaccines can induce long-lived, and in some cases, high-titer neutralizing antibodies that are likely protective against EMCV-related disease in elephants.
“These results suggest that killed autogenous vaccines – which in most circumstances are the only current option available to zoos for protecting their animals – can nevertheless induce long-lived, and in some cases, high-titer neutralizing antibodies that are likely protective against EMCV-related disease in elephants.”
From Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak (2026) · cites this paper as [32]
Cites
Doel, T. R., Williams, L., & Barnett, P. V. (1994) · Vaccine · doi:10.1016/0264-410x(94)90262-3 · Cited by 195 · see citing works
An encephalomyocarditis virus epizootic in a baboon colony.
Gb, H., Soike, K. F., Tm, B., Kd, C., Davis, H., Butcher, W. I., & Gauntt, C. J. (1992) · PubMed · Cited by 76 · see citing works
Grobler, D., Raath, J. P., Braack, L., Keet, D. F., Gerdes, G. H., Barnard, B. J. H., Kriek, N. P. J., Jardine, J., & Swanepoel, R. (1995) · PubMed · doi:10.5281/zenodo.13537728 · Cited by 64 · see citing works
Self-citationGordon, D. H., & Watson, C. R. B. (1986) · South African Journal of Zoology · doi:10.1080/02541858.1986.11447965 · Cited by 57 · see citing works
Osorio, J. E., Hubbard, G. B., Soike, K. F., Girard, M., van der Werf, S., Moulin, J.-C., & Palmenberg, A. C. (1996) · Vaccine · doi:10.1016/0264-410x(95)00129-o · Cited by 41 · see citing works
Doel, T. R., Fletton, B. W., & Staple, R. F. (1981) · PubMed · Cited by 36 · see citing works
Encephalomyocarditis virus infection of captive elephants
Simpson, C. F., Lewis, A. L., & Gaskin, J. M. (1977) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1977.171.09.902 · Cited by 33 · see citing works
HUNTER, P. (1996) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.15.3.954 · Cited by 32 · see citing works
Self-citationAn association between encephalomyocarditis virus infection and reproductive failure in pigs
Links, I., Whittington, R. J., KENNEDY, D. J., et al. (1986) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.1986.tb02954.x · Cited by 26 · see citing works
Christianson, W. T., Kim, H. S., Joo, H. S., et al. (1990) · PubMed · Cited by 25 · see citing works
Jj, E., Gr, T., Flammand, et al. (1985) · PubMed · Cited by 22 · see citing works
Esterhuysen, J. J., Thomson, G. R., Ashford, W. A., et al. (1988) · PubMed · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Flacke, G. L., Tkalčić, S., Steck, B., Warren, K., & Martin, G. B. (2016) · Zoo Biology · doi:10.1002/zoo.21336 · Cited by 20 · see citing works
Romey, A., Lamglait, B., Blanchard, Y., Touzain, F., Quenault, H., Relmy, A., Zientara, S., Blaise-Boisseau, S., & Bakkali-Kassimi, L. (2021) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638720978389 · Cited by 16 · see citing works
Encephalomyocarditis Virus Infection in Zoo Animals.
Backues, K. A. (2008) · Zoo and Wild Animal Medicine · doi:10.1016/b978-141604047-7.50012-9 · Cited by 7 · see citing works
van Meer, V., Pawęska, J. T., Swanepoel, R., Grobbelaar, A., & Bastos, A. D. (2024) · Pathogens · doi:10.3390/pathogens13030261 · Cited by 5 · see citing works
Vaccination of llamas, Llama glama, with an experimental killed encephalomyocarditis virus vaccine
Kilburn, J. J., Murphy, D. P., Titus, M., Payton, M. E., & Backues, K. A. (2011) · Journal of Zoo and Wildlife Medicine · doi:10.1638/2010-0057.1 · Cited by 5 · see citing works
Adhikari, A., Feng, K. H., Shrestha, A., Rodriguez, C. E., Nolan, E. C., Pye, G. W., Gauger, P. C., Denagamage, T., Holmes, E. C., & Allison, A. B. (2026) · PLOS Pathogens · doi:10.1371/journal.ppat.1013861 · Cited by 1 · see citing works
“…in strong levels of cross-reactivity to EMCV in neutralization tests, it is likely suggestive that zoo animals may be exposed to EMCV more frequently than believed and that infection in elephants may not always result in severe clinical disease, as has been observed previously in some cases [32].”
- Authors
- Hunter, P., Swanepoel, S. P., Esterhuysen, J. J., Raath, J. P., Bengis, R. G., & van der Lugt, J. J.
- Affiliations
- South African National Parks (ZA)
- Corresponding author
- Hunter, Pamela
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 1998-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 55-61
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2044067805
- Cited by
- 39
- References
- 12
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Agricultural and Biological Sciences › Agronomy and Crop Science › Animal Disease Management and Epidemiology
- Keywords
- encephalomyocarditis virus, inactivated vaccine, oil adjuvant, vaccine efficacy, elephants, myocarditis, antibody titers, pigs, mice, zoological collections, pork industry
- MeSH terms
- Adjuvants, Immunologic, Animals, Elephants, Encephalomyocarditis virus, South Africa, Swine, Viral Vaccines, Vaccines, Inactivated, Cardiovirus Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review